Primary antibiotic resistance and effectiveness of helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract

Acta Gastro-Enterologica Belgica

Volumn 68, Issue 3, 2005, Pages 287-293

  Aguemon, Badirou ^a,b   Struelens, Marc ^a,b   Devière, Jacques ^b   Denis, Olivier ^b   Golstein, Philippe ^b   Salmon, Isabelle ^b   Nagy, Nathalie ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Antibiotic resistance; Eradication; H. pylori; Stool antigen test; Triple therapy

Indexed keywords

AMOXICILLIN; BACTERIAL ANTIGEN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION; DIGESTIVE TRACT ENDOSCOPY; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; GASTROINTESTINAL INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; UREA BREATH TEST;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTIBODIES, BACTERIAL; BIOPSY; BREATH TESTS; CHILD; CLARITHROMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; STOMACH ULCER; TREATMENT OUTCOME; UREA;

EID: 26944461226     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. VINCENT P., GOTTRAND F., LECLERC H. Epidémiologie d'Helicobacter pylori: disparités dans la distribution de l'infection. Gastroenterol. Clin. Biol., 1996, 20: S27-S33.
2. GLUPCZYNSKI Y. Microbiological and serological diagnostic tests for Helicobacter pylori: an overview. Acta Gastroenterol. Belg., 1998, 61: 321-326.
3. 2 breath test and stable isotopes for investigating gastrointestinal functions. Expert point of view. Acta Gastroenterol. Belg., 2000, 63: 325.
4. l3C-aminopyrine breath test using nondispersive infrared spectrometry. Acta Gastroenterol. Belg., 2000, 63: 328-330.
5. Conclusions et recommandations révisées du groupe de travail. Conférence de consensus Helicobacter pylori - Révision, 1999. Gastroenterol. Clin. Biol., 23: C95-C104.
6. HOUBEN M.H.M.G., VAN DE BEEK D., HENSEN E.F., DE CRAEN A.J.M., RAUWS A.J., TYTGAT G.N.J. A systematic review of Helicobacter pylori eradication therapy - the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol. Ther., 1999, 13: 1047-1055.
7. AGUEMON B., STRUELENS M., DEVIÈRE J., DENIS O., GOLSTEIN P., NAGY N., SALMON I. Evaluation of stool antigen detection for diagnosis of Helicobacter pylori infection in adults. Acta Clin. Belg., 2004, 59: 246-250.
8. BOMMELAER G. et al. Statut cagA et virulence des souches de Helicobacter pylori: Résultats d'une étude multicentrique prospective française. Gastroenterol. Clin. Biol., 2001, 25: 1084-1089.
9. BROUTET N. Prévalence actuelle de l'infection à Helicobacter pylori et tendances évolutives en Europe. Lettre Infectiologie, 2000, Suppl. 3: 28-29.
10. LAHAIE R.G., LAHAIE M.A., BOIVIN M., GAGNON M., LEMOYNE M. La prévalence de l'infection à Helicobacter pylori: tendances évolutives en Amérique du Nord. Lettre Infectiologie, 2000, Suppl. 3: 18-22.
11. BURETTE A., DELTENRE M., BELAËCHE J., DEVOS M. H. pylori infection diagnosis in gastro-duodenal ulcers in Belgium: A national endoscopy survey. Gut, 2001, 49: Abstract Suppl. A36.
12. 13C-urea breath test with serology. J. Gerontol. A Biol. Sci. Med. Sci., 2000, 55: 163-167.
13. ANDERSEN L.P., BOYE K., BLOM J., HOLCK S., NORGAARD A., ELSBORG L. Characterisazation of a culturable "Gastrospirillum hominis" (Helicobacter helmannii) strain isolated from human gastric mucosa. J. Clin. Microbiol., 1999, 37: 1069-1076.
14. DE GROOTE D., DUCATELLE R., HAESEBROUCK F. Helicobacters of possible zoonotic origin: a Review. Acta Gastroenterol. Belg., 2000, 63: 380-387.
15. GLUPCZYNSKIY, MÉGRAUD F., LOPEZ-BREA M., ANDERSEN L.P. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis., 2001, 20: 820-823.
16. DELCHIER J.C., ROUDOT-THORAVAL F., COURILLON-MALLET A. Traitement de l'infection à Helicobacter pylori en pratique courante: résultats d'une enquête multicentrique nationale (abstract). Gastroenterol. Clin. Biol., 2001, 25: A8
17. WOLLE K., LEODOLTER A. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J. Med. Microbiol., 2002, 51: 705-709.
18. FRANZIN L., PENNAZIO M., CABODI D., ROSSINI P.P., GIOVANNI P. Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or dudenal ulcer in Italy. Curr. Microbiol., 2000, 40: 96-100.
19. MEGRAUD F. Epidemiology and mechanisms of antibiotic resistance in Helicobacter pylori. Gastroenterol. Clin. Biol., 1998, 115: 1278-1282.
20. DELCHIER J.C. Comment éradiquer Helicobacter pylori? Gastroenterol. Clin. Biol., 1999, 23: 20-33.
21. BONTEMS P., DEVASTER J.M., CORVAGLIA L., DEZSOFI A., VAN DEN BORRE C., GOUTIER S. et al. Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children. Pediatr. Infect. Dis. J., 2001, 20: 1033-1038.
22. GLUPCZYNSKI Y., NIZET H., BERHIN C., MARTINET J., MELANGE M., DEPREZ P. Prevalence of primary antibiotic resistance in Helicobacter pylori at two different locations in Belgium (1998-2000) abstract. Helicobacter, 2004, 9: 585-586.
23. GLUPCZYNSKI Y., BURETTE A., BERHIN C., BELGIAN H. PYLORI STUDY GROUP (BHPSG). A multicentric survey of antimicrobial resistance of H. pylori in Belgium in 2003 (abstract). Helicobacter, 2004, 9: 584-585.
24. GRIGNON B., TANKOVIC J., MEGRAUD F., GLUPCZYNSKI Y., HOUSSON M.O., CONROY M.C. et al. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb. Drug Resist., 2000, 8: 61-66.
25. SHEPERD A.J., WILLIAM C. Comparison of an enzyme immunoassay for detection of Helicobacter pylori antigens in the faeces with the urea breath test. Arch. Dis. Child, 2000, 83: 268-270.
26. 13C-urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: prospective clinical evaluation. Brit. Med. J., 2000, 320: 148.
27. ALTINDIS M., DILEK O.N. Usefulness of the Helicobacter pylori stool antigen test for detection of Helicobacter pylori infection. Acta Gastroenterol. Belg., 2002, 15: 74-76.
28. ODAKA T., YAMAGUCHI T., KOYAMA H., SAISHO H. Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy. Am. J. Gastroenterol., 2002, 97: 594-599.
29. OHKURA R., MIWA H., NAGAHARA A., OHTA K., SATA K., YAMADA T., SATO N. Usefulness of a novel enzyme immunoassay for the detection of Helicobacter pylori. Scand. J. Gastroenterol., 2000, 1: 49-53.
30. DELCHIER J.C., ROUDOT F., GUIASU I.M. Evaluation de l'efficacité du traitement éradicateur de l'infection à Helicobacter pylori en France: résultats préliminaires de l'enquête du GEFH. Lettre Infectiologie, 2000, Suppl. 3: 9-10.
31. GISBERT J.P., GONZALEZ L., CALVET X., ROQUE M., GABRIEL R. Proton pump inhibitor, clarithromycin and either amoxicillin or nitroimidazole: a metanalysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther, 2000, 14: 1319-1328.
32. WERMEILLE J., CUNNINGHAM M., DEDERDING J.P., GIRARD L., BAUMANN R., ZELGER G. et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol. Clin. Biol., 2002, 26: 216-219.